EcoDrugPlus

Ensembl ID : ENSPTIG00000016981
Gene Symbol: TUBA1A
1 Cross references
198 Possible Orthologues:

Ensembl ID : ENSPTIG00000008626
Gene Symbol: -
Cross references: -
376 Possible Orthologues:

Ensembl ID : ENSPTIG00000006521
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSPTIG00000006143
Gene Symbol: -
Cross references: -
470 Possible Orthologues:

Ensembl ID : ENSPTIG00000020469
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSPTIG00000005018
Gene Symbol: -
Cross references: -
68 Possible Orthologues:

Ensembl ID : ENSPTIG00000005063
Gene Symbol: -
Cross references: -
149 Possible Orthologues:

Ensembl ID : ENSPTIG00000005030
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSPTIG00000020781
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSPTIG00000005017
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).